[ Science 37 raises $29M in Series C ]

Science 37 has raised $29 million in Series C funding.

Founded in 2014, Science 37 takes a mobile-first approach to running clinical trials, as it works to more easily connect patients with scientists by eroding geographical barriers.

The company’s latest cash injection will be used to expand its platform and further recruitment efforts.

Funding  Series C
Founded  2014
Country  USA
City  Los Angeles, California
Founder / CEO  Noah Craft
Deal Size  $29M
Investors  Amgen Ventures
 Sanofi-Genzyme BioVentures
 Glynn Capital Management
 GV
 Lux Capital
 Redmile Group
 dRx Capital
Previous Investors  Sanofi-Genzyme BioVentures
 Lux Capital
 Redmile Group
 dRx Capital